91 related articles for article (PubMed ID: 9355963)
1. Differential neutralizing activity of human antibodies in interferon antiviral and natural killer cell bioassays.
Thurmond LM; Reese MJ
J Interferon Cytokine Res; 1997 Oct; 17(10):619-23. PubMed ID: 9355963
[TBL] [Abstract][Full Text] [Related]
2. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
3. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
4. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
6. Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.
Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
J Immunol Methods; 2009 Oct; 350(1-2):89-96. PubMed ID: 19733573
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells inhibit hepatitis C virus expression.
Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
[TBL] [Abstract][Full Text] [Related]
8. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
[TBL] [Abstract][Full Text] [Related]
9. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
11. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
[TBL] [Abstract][Full Text] [Related]
12. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
13. Relationship between natural killer (NK) cells and interferon (IFN) alpha-producing cells in human peripheral blood. Studies with a monoclonal antibody with specificity for human natural killer cells.
Abb J; Abb H; Deinhardt F
Immunobiology; 1984 Oct; 167(4):359-64. PubMed ID: 6510947
[TBL] [Abstract][Full Text] [Related]
14. The neutralization of interferons by antibody. I. Quantitative and theoretical analyses of the neutralization reaction in different bioassay systems.
Grossberg SE; Kawade Y; Kohase M; Yokoyama H; Finter N
J Interferon Cytokine Res; 2001 Sep; 21(9):729-42. PubMed ID: 11576467
[TBL] [Abstract][Full Text] [Related]
15. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
[TBL] [Abstract][Full Text] [Related]
16. Comparison of augmentation of human natural killer cell cytotoxicity by interferon-alpha subtypes.
Verhagen A; Mackay IR; Rowley M; Tymms M
Nat Immun Cell Growth Regul; 1990; 9(5):325-33. PubMed ID: 2077397
[TBL] [Abstract][Full Text] [Related]
17. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
Chong AS; Scuderi P; Grimes WJ; Hersh EM
J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
[TBL] [Abstract][Full Text] [Related]
18. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha.
Kutza J; Murasko DM
Cell Immunol; 1994 Apr; 155(1):195-204. PubMed ID: 7513259
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
[TBL] [Abstract][Full Text] [Related]
20. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
